Ibisobanuro
Omeprazole yacu hagati ya 2.3.5-Trimethyl-4-nitropyridine-N-oxyde yakozwe neza kugirango yujuje ubuziranenge bwo mu nganda, ireme neza kandi ikora neza kandi irashobora gukoreshwa muburyo butandukanye bwa shimi na farumasi.Hamwe nimiterere yabyo hamwe nubuziranenge budasanzwe, iyi nteruro ni amahitamo meza kubashakashatsi, abahanga ninzobere mu bya farumasi bashaka abahuza bizewe, bakora neza cyane mumishinga yabo.
Hagati aho igira uruhare runini mu gukora omeprazole, imiti ikoreshwa cyane mu kuvura indwara ziterwa na aside nka gastroesophageal reflux disease (GERD), ibisebe bya peptike, na zoline (syndrome de Guardian-Ellison).Nkibice byingenzi muguhuza omeprazole, omeprazole yacu hagati ya 2.3.5-trimethyl-4-nitropyridine-N-oxyde yorohereza umusaruro unoze kandi uhenze cyane wiyi miti yingenzi yimiti.
Hitamo
JDK ifite ibikoresho byo mu rwego rwa mbere n’ibikoresho byo gucunga ubuziranenge, byizeza itangwa rihamye ry’abahuza API.Itsinda ryumwuga ryizeza R&D yibicuruzwa.Kurwanya byombi, turimo gushakisha CMO & CDMO kumasoko yimbere mu gihugu no mumahanga.